| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 519c | 0.890 | 0.077 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2019 | |||||||||
|
tubulin folding cofactor B | 0.931 | 0.115 | 1.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
NOP2/Sun RNA methyltransferase 6 | 0.805 | 0.154 | 4.9E-19 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
N-acetylglucosamine kinase | 0.931 | 0.154 | 4.6E-09 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
glycerophosphocholine phosphodiesterase 1 | 0.931 | 0.154 | 0.20 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2014 | ||||||||
|
SWI/SNF complex antagonist associated with prostate cancer 1 | 0.751 | 0.192 |
|
phenotype | 0.330 | None | 1.000 | 1 | 0 | 2013 | 2018 | |||||||||
|
LLGL scribble cell polarity complex component 2 | 0.769 | 0.192 | 2.9E-12 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
mediator complex subunit 28 | 0.780 | 0.192 | 1.1E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
cytosolic thiouridylase subunit 1 | 0.769 | 0.192 | 6.7E-02 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2013 | 2016 | ||||||||
|
eukaryotic translation initiation factor 1A X-linked | 0.716 | 0.231 | 0.91 |
|
phenotype | 0.380 | None | 0.889 | 1 | 0 | 2007 | 2019 | ||||||||
|
elongator acetyltransferase complex subunit 3 | 0.751 | 0.231 | 3.0E-14 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
microRNA 564 | 0.695 | 0.269 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2018 | |||||||||
|
endoplasmic reticulum protein 29 | 0.716 | 0.308 | 0.75 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
ras homolog family member C | 0.641 | 0.308 | 0.77 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
eukaryotic translation elongation factor 1 beta 2 | 0.751 | 0.346 | 6.6E-02 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2010 | ||||||||
|
MNX1 antisense RNA 1 (head to head) | 0.615 | 0.346 |
|
phenotype | 0.360 | None | 1.000 | 1 | 0 | 2017 | 2020 | |||||||||
|
microRNA 595 | 0.722 | 0.346 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2017 | |||||||||
|
cyclin dependent kinase like 2 | 0.751 | 0.346 | 3.1E-17 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ubiquitin C-terminal hydrolase L3 | 0.705 | 0.385 | 3.3E-08 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
matrix metallopeptidase 24 | 0.743 | 0.423 | 0.68 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cytosolic thiouridylase subunit 2 | 0.695 | 0.423 | 4.0E-22 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
E2F transcription factor 8 | 0.674 | 0.423 | 0.82 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2019 | ||||||||
|
solute carrier family 39 member 6 | 0.656 | 0.462 | 4.9E-07 |
|
phenotype | 0.380 | None | 0.889 | 1 | 0 | 2003 | 2018 | ||||||||
|
histamine receptor H2 | 0.647 | 0.462 | 0.12 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 0.691 | 0.462 | 1.00 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2011 | 2016 |